These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7501098)
1. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits]. Schaller C; Rohde V; Hassler W Nervenarzt; 1995 Oct; 66(10):792. PubMed ID: 7501098 [No Abstract] [Full Text] [Related]
2. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits]. Schaller C; Rohde V; Hassler W Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814 [TBL] [Abstract][Full Text] [Related]
3. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
4. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and tolerance of rt-Pa for local lytic therapy of 53 embolic and thrombotic occlusions of the lower extremity]. Spengel FA; Küffer G; Hufen V; Stiegler H Vasa Suppl; 1991; 33():127. PubMed ID: 1788642 [No Abstract] [Full Text] [Related]
6. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related]
7. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364 [TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy for acute ischemic stroke. Kelley RE J La State Med Soc; 2000 May; 152(5):253-8. PubMed ID: 10875215 [TBL] [Abstract][Full Text] [Related]
9. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator. Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window. Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954 [TBL] [Abstract][Full Text] [Related]
12. Fibrinolysis and aspiration of experimental intracerebral hematoma reduces the volume of ischemic brain in rats. Deinsberger W; Vogel J; Fuchs C; Auer LM; Kuschinsky W; Böker DK Neurol Res; 1999 Jul; 21(5):517-23. PubMed ID: 10439435 [TBL] [Abstract][Full Text] [Related]
13. Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis. Levin D; Smith DB; Cumbler E; Carter J; Glasheen JJ; Jones W Arch Neurol; 2011 Jan; 68(1):135; author reply 135-6. PubMed ID: 21220688 [No Abstract] [Full Text] [Related]
14. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
15. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction]. Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219 [No Abstract] [Full Text] [Related]
16. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085 [TBL] [Abstract][Full Text] [Related]
17. Emergency Bedside Catheter Evacuation of Deep Ganglionic Hematoma Following Recanalization Therapy in Ischemic Stroke. Lambeck J; Steiert C; Bardutzky J Neurocrit Care; 2023 Feb; 38(1):165-170. PubMed ID: 36071332 [No Abstract] [Full Text] [Related]
18. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV; Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474 [TBL] [Abstract][Full Text] [Related]
19. Risk of thrombolysis-associated intracerebral hemorrhage: the need to compare apples with apples. Khatri P; Broderick JP; Pancioli AM Stroke; 2005 Jun; 36(6):1109-10; author reply 1110. PubMed ID: 15914762 [No Abstract] [Full Text] [Related]
20. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]